Diastolic dysfunction is associated with low urinary sodium excretion in patients with decompensated cirrhosis

Evangelos Cholongitas1, Ioannis Goulis1, Efstathios Pagourelias2

  • 14th Department of Internal Medicine, Hippokration General Hospital, Medical School Aristotle University of Thessaloniki, Greece.

Annals of Hepatology
|August 6, 2016
PubMed

Insights

Diastolic dysfunction in cirrhosis is linked to lower 24-hour urine sodium levels. This study identified pulse rate and urine sodium as key factors, though not directly impacting liver disease severity or survival.

Area of Science:

  • Cardiology
  • Hepatology
  • Transplantation Medicine

Background:

  • Diastolic dysfunction (DD) in cirrhosis pathogenesis and clinical impact are not fully understood.
  • Patients with decompensated cirrhosis awaiting liver transplantation are a vulnerable population.
  • Understanding factors associated with DD is crucial for managing these patients.

Purpose of the Study:

  • To investigate factors associated with diastolic dysfunction in patients with decompensated cirrhosis.
  • To identify predictors of DD in liver transplant candidates.
  • To clarify the clinical impact of DD in this cohort.

Main Methods:

  • Prospective evaluation of 115 consecutive patients with decompensated cirrhosis undergoing transplant assessment.
  • Diagnosis of DD using Doppler echocardiography, classified per current guidelines.
  • Multivariable logistic regression analysis to identify independent predictors of DD.

Main Results:

  • Diastolic dysfunction was present in 57.3% of patients.
  • Pulse rate and lower 24-hour urine sodium (UNa24h) were independently associated with DD.
  • Patients with DD showed higher levels of interleukin-6 compared to those without DD.

Conclusions:

  • Diastolic dysfunction in decompensated cirrhosis is independently associated with lower 24-hour urine sodium.
  • No correlation was found between DD and liver disease severity (Child-Pugh/MELD scores) or patient survival.
  • Further research is warranted to fully elucidate the implications of DD in cirrhosis.
Abstract

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.7K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.6K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
506
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
548
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K